Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification

Withdrawn before enrolling · Not applicable

Conditions studied: Nicotine Addiction, Drug Addiction, Drug Dependence, Substance Use Disorder, Tobacco Dependence

In brief

This study is evaluating the efficacy of Treatment A for short-term smoking cessation through a blinded randomized controlled trial (RCT) vs.Treatment B.

Key facts

Study ID

NCT05440721

Run by

Click Therapeutics, Inc.

People needed

0

Starts

2018-10-25

Expected to finish

2022-08-01

Last updated by the study team

2022-07-01

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 18 to 65
• Smokes at least 5 cigarettes daily
• Is interested in quitting in the next 30 days
• Owns an iPhone with iOS 9 or higher or Android with OS 4.1 or higher
• Willing and able to receive SMS text messages
• Able to comprehend the English-language and the informed consent form
• Lives in the United States
• One half of the study sample will be recruited from the general population of smokers via social media advertisements
• One half of the study sample will be recruited via mail from a Magellan Behavioral Health value-based care network

You may not qualify if…

• Prior use of Clickotine or QuitGuide
• Current use of pharmacotherapy for smoking cessation or nicotine replacement therapy (NRT)

Where it is running

• Click Therapeutics — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.